Showing 641 - 660 results of 1,132 for search '"immunosuppression"', query time: 0.05s Refine Results
  1. 641

    Review on the Relationship between Human Polyomaviruses-Associated Tumors and Host Immune System by Serena Delbue, Manola Comar, Pasquale Ferrante

    Published 2012-01-01
    “…To date, at least nine members of the Polyomaviridae family have been identified, some of them playing an etiological role in malignancies in immunosuppressed patients. Here, we describe the biology of human polyomaviruses, their nonmalignant and malignant potentials ability, and their relationship with the host immune response.…”
    Get full text
    Article
  2. 642

    Iatrogenic T-Cell Lymphoma with Associated Hemophagocytic Lymphohistiocyotsis in a Patient with Long-Standing Rheumatoid Arthritis by X. A. Andrade, H. E. Fuentes, D. M. Oramas, H. Mann, P. Kovarik

    Published 2018-01-01
    “…Patients with rheumatoid arthritis are at increased risk of hematological malignancies, especially when exposed to immunosuppressive therapy. The mechanisms of lymphomagenesis remain poorly understood but factors implicated include high disease activity, exposure to antitumoral necrosis factor medications, and Epstein–Barr virus infection. …”
    Get full text
    Article
  3. 643

    Bullous pemphigoid as a diagnostic and therapeutic challenge with a wide spectrum of dermatological symptoms by Przemysław Borowy, Olga Wcisłek, Julia Płonczyńska, Mateusz Heba, Bogdan Batko

    Published 2025-01-01
    “…The treatment involves the use of topical or systemic glucocorticosteroids (GCS) and, in challenging cases, immunosuppressive drugs. In a 74-year-old patient with internistic and psychiatric burdens, and oral lesions present for the several past months. …”
    Get full text
    Article
  4. 644

    Updates in the management of connective tissue disease-associated interstitial lung disease by Chengappa Kavadichanda, G S R S N K Naidu

    Published 2021-01-01
    “…Insights into the pathology of these diseases and the associated lung involvement have resulted in the emergence of several immunosuppressive, antifibrotic, and small molecules as alternatives in CTD-ILD. …”
    Get full text
    Article
  5. 645

    A Rare Case of Meningitis Caused by Alcaligenes faecalis in an Immunocompetent Patient by Kevin Cantillo García, Oscar Calderón Duran, Tomás Acosta Pérez, Ángel Vásquez Jiménez, Emerson Madrid Pérez, María Cristina Martínez-Ávila, Tomás Rodríguez Yánez, Amilkar Almanza-Hurtado

    Published 2022-01-01
    “…The first cases of infections caused by this microorganism, such as pneumonia, soft tissue infections, urinary tract infections, bacteremia, and meningitis, date back more than 40 years and are almost entirely in newborns and immunosuppressed hosts. Optimal antibiotic therapy for A. faecalis has not been well established in the literature. …”
    Get full text
    Article
  6. 646

    Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient by Samuel Chan, Michael T. Burke, David W. Johnson, Ross S. Francis, David W. Mudge

    Published 2017-01-01
    “…The immunosuppressant tacrolimus has a narrow therapeutic window, necessitating therapeutic drug monitoring to maintain efficacy and minimise toxicity. …”
    Get full text
    Article
  7. 647
  8. 648

    Management of Metachronous Bilateral Testis Cancer in a Patient with Pre-B Cell ALL by Kelly T. Harris, Shakil A. Shaikh, Mark W. Ball, Mohamad E. Allaf, Phillip M. Pierorazio

    Published 2015-01-01
    “…We discuss the management of bilateral testis masses in a young patient with a hematologic malignancy as well as the role of immunosuppressive chemotherapy in developing a second cancer. …”
    Get full text
    Article
  9. 649

    New Onset Granulomatosis with Polyangiitis Associated with COVID-19 by Moshe Y. Bressler, Naeha Pathak, Kelly Cervellione, Farshad Bagheri, Edward Epstein, Adnan Mir, Rebecca Tamez

    Published 2021-01-01
    “…Symptoms often overlap between the two diseases, and while there is no current cure for COVID-19, rapid immunosuppressive initiation can be lifesaving for patients with GPA. …”
    Get full text
    Article
  10. 650

    Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective by Michel Laverdiere, Eric J Bow, Coleman Rotstein, Julie Autmizguine, Raewyn Broady, Gary Garber, Shariq Haider, Trana Hussaini, Shahid Husain, Philippe Ovetchkine, Jack T Seki, Yves Théorêt

    Published 2014-01-01
    “…Invasive fungal infections cause significant morbidity and mortality in patients with concomitant underlying immunosuppressive diseases. The recent addition of new triazoles to the antifungal armamentarium has allowed for extended-spectrum activity and flexibility of administration. …”
    Get full text
    Article
  11. 651

    Cerebral Wegener’s Granuloma: Surgery Mandatory for Diagnosis and Treatment by Federico Nicolosi, Giovanni Nodari, Giannantonio Spena, Elena Roca, Karol Migliorati, Giacomo Esposito, Roberto Stefini, Marco Fontanella, Pier Paolo Panciani

    Published 2013-01-01
    “…The importance of a surgery in case of localized WG has been emphasized, in order to confirm the diagnosis and to avoid additional medicaments, like antiepileptic drugs, potentially harmful in immunosuppressed patients.…”
    Get full text
    Article
  12. 652

    Cotrimoxazole-Induced Hypoglycaemia in a Patient with Churg-Strauss Syndrome by Russell Senanayake, Mamoun Mukhtar

    Published 2013-01-01
    “…Cotrimoxazole is a commonly used antimicrobial agent which is traditionally indicated in the management of pneumocystis infection of which HIV and immunosuppressed individuals are at high risk. Furthermore, it can be used on the long term for prophylactic indications. …”
    Get full text
    Article
  13. 653

    Successful Use of Posaconazole to Treat Invasive Cutaneous Fungal Infection in a Liver Transplant Patient on Sirolimus by Randah Dahlan, Ameen Patel, Shariq Haider

    Published 2012-01-01
    “…The high morbidity and mortality associated with these infections necessitates urgent therapy with antifungal drugs; however, the interaction between these drugs and immunosuppressive therapies can be a major limitation because of drug toxicity. …”
    Get full text
    Article
  14. 654
  15. 655

    Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil by Takashi Nawata, Makoto Kubo, Kosaku Shiragami, Yukinori Nakamura, Masafumi Yano

    Published 2017-01-01
    “…HLH associated with autoimmune diseases is often refractory to corticosteroid treatment; thus, additional immunosuppressive drugs, such as cyclosporine, cyclophosphamide, or tacrolimus, are required. …”
    Get full text
    Article
  16. 656

    Severe Respiratory Distress in a Child with Pulmonary Idiopathic Hemosiderosis Initially Presenting with Iron-Deficiency Anemia by A. Potalivo, L. Finessi, F. Facondini, A. Lupo, C. Andreoni, G. Giuliani, C. Cavicchi

    Published 2015-01-01
    “…The suspicion of IPH led to the use of immunosuppressive therapy with high dose of corticosteroids with rapid improvement in clinical condition and discharge from hospital.…”
    Get full text
    Article
  17. 657

    Harnessing amino acid pathways to influence myeloid cell function in tumor immunity by Jiongli Pan, Yi Lin, Xinyuan Liu, Xiaozhen Zhang, Tingbo Liang, Xueli Bai

    Published 2025-02-01
    “…Within the tumor microenvironment, amino acid metabolism plays a crucial role in mediating the immunosuppressive functions of myeloid cells, contributing to tumor progression. …”
    Get full text
    Article
  18. 658

    Improving CD3 bispecific antibody therapy in solid tumors using combination strategies by Katy Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, Nora Pencheva, Kristel Kemper, Thorbald van Hall

    Published 2025-02-01
    “…Despite these recent advances, the success of CD3 bsAbs in solid cancer has been hampered by hurdles like limited intratumoral T cell numbers, immunosuppressive tumor microenvironments (TME), and poor memory T-cell induction. …”
    Get full text
    Article
  19. 659

    A Case of Systemic Lupus Erythematosus Presenting as Guillain-Barré Syndrome by Helen Chioma Okoh, Sandeep Singh Lubana, Spencer Langevin, Susan Sanelli-Russo, Adriana Abrudescu

    Published 2015-01-01
    “…We are reporting a rare case of Miller-Fisher (MFS) variant of Guillain-Barré syndrome (GBS) as the first manifestation of SLE in a 41-year-old female who progressed to flaccid paralysis with no neurological improvement with initial immunosuppressive therapy, plasmapheresis, and first cycle of intravenous immunoglobulin (IVIG) but with remarkable and complete recovery after the second 5-day course of IVIG.…”
    Get full text
    Article
  20. 660

    Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases by Matthew Koslow, Mehrnaz Maleki-Fischbach, Rebecca C. Keith

    Published 2021-01-01
    “…In the absence of guidelines regarding how CTD-ILDs should be treated, clinicians face difficult decisions on when to use immunosuppressant and anti-fibrotic therapies. The importance of a multidisciplinary and individualized approach to the diagnosis and management of CTD-ILD is highlighted in the three case studies that we describe in this article.…”
    Get full text
    Article